Vertical: HealthcareBase Year: 202422 Sections
Market Size (2024)
$244.18M
Projected (2035)
$475.78M
CAGR (2019–2035)
6.6%
Key Players
10+
This report covers Citicoline Ingredients Market with forecasts from 2019 to 2035. 10 key companies are profiled.
The Citicoline Ingredients Market market is projected to grow at a CAGR of 6.6% from 2019 to 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The increasing incidence of various diseases worldwide, the growing number of product launches featuring citicoline, and the rising adoption of preventive and personalized nutrition are key factors driving the growth of the global citicoline ingredient market. However, stringent regulatory policies and a lack of consumer awareness in emerging markets are expected to hamper market expansion. Nevertheless, the growing geriatric population and the heightened focus on mental health and wellness in the post-pandemic era are anticipated to create lucrative opportunities for industry.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2024
Historical Period
2019 – 2023
Forecast Period
2025 – 2035
Primary Interviews
150+
Historical data (2019–2024) and forecast period (2024–2035)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter's Five Forces model is a framework to study the global citicoline ingredient market. Strategic business managers trying to gain an edge over competing firms in the global citicoline ingredient market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the global citicoline ingredient market have been broken down and analyzed.
PORTER'S FIVE FORCES Analysis: Global Citicoline Ingredient Market
Threat of New Entrants
The threat of new entrants in the global citicoline ingredient market is moderate to high. While the market offers lucrative opportunities due to growing demand for cognitive health solutions, there are notable entry barriers such as stringent regulatory requirements, scientific validation needs, and high initial R&D costs. New entrants must comply with food safety and labeling laws across different regions, including standards set by the FDA, EMA, and other national authorities. However, technological advancements, increased access to contract manufacturing, and the rise of e-commerce platforms are lowering barriers for startups and smaller players. This has led to a growing influx of nutraceutical and functional food companies entering the market with citicoline-based offerings, intensifying competitive pressure.
BARGAINING POWER OF SUPPLIERS
The bargaining power of suppliers in the citicoline ingredient market is moderate. While high-quality and clinically validated citicoline ingredients are produced by a limited group of specialized manufacturers, which gives suppliers some leverage—particularly for premium-grade or patented variants, this power is balanced by the growing availability of generic alternatives. The expansion of manufacturing capabilities in regions such as Asia has increased the number of supply sources, reducing buyer dependency on any single supplier. As a result, buyers have more flexibility in sourcing options and negotiating terms. However, for businesses that prioritize clinically supported or high purity citicoline for use in premium formulations, suppliers still maintain a relatively stronger position due to limited substitutes of comparable quality.
Threat of Substitutes
The threat of substitutes in the global citicoline market is high. Numerous other ingredients offer similar cognitive benefits, including L-theanine, omega-3 fatty acids, ginkgo biloba, Bacopa monnieri, and synthetic compounds such as modafinil. Many of these alternatives are better known to consumers, more widely available, or more cost-effective. Additionally, non-ingredient-based alternatives such as cognitive training apps, mindfulness practices, and other mental wellness programs are increasingly being adopted for brain health. The wide range of substitutes limits citicoline’s ability to dominate the market and puts pressure on producers to continuously innovate and differentiate their offerings.
Bargaining Power of Buyers
The bargaining power of buyers is high, particularly in mature markets where customers are well-informed and have access to a broad range of cognitive health solutions. Buyers—including supplement brands, functional food manufacturers, and end consumers demand scientifically supported, high-quality ingredients at competitive prices. Large buyers, such as multinational nutraceutical or beverage companies, have strong negotiating power due to bulk purchasing and the ability to switch suppliers easily. Even at the consumer level, growing awareness and access to online platforms have made it easier for individuals to compare products, read reviews, and choose alternatives—placing significant pressure on suppliers and product developers to maintain transparency, efficacy, and cost competitiveness.
Intensity of Rivalry
The intensity of rivalry in the citicoline ingredient market is high. The market is crowded with numerous ingredient suppliers, private-label manufacturers, and consumer-facing brands competing for a share in the growing brain health segment. Companies are vying for differentiation through branded ingredients, clinical research, marketing claims, and innovative product formats such as ready-to-drink beverages or nootropic stacks. Furthermore, the global push toward cognitive wellness, mental performance, and preventive health has encouraged new players to enter space, increasing competition. As product innovation accelerates and pricing pressure mounts, rivalry continues to intensify, making it essential for players to invest in branding, quality assurance, and consumer engagement to maintain market position.
Impact of covid-19 on the Global Citicoline Ingredient Market
The COVID-19 pandemic exerted a transformative influence on the global citicoline ingredient market, presenting a mix of complex challenges and strategic opportunities that reshaped the industry's overall trajectory. As mental health and cognitive wellness emerged as key health priorities during the crisis, there was a notable increase in consumer demand for brain-health-enhancing supplements. Heightened psychological stress, remote work fatigue, and the cognitive impairments reported among post-COVID-19 patients fueled this shift, positioning citicoline—a well-known neuroprotective and cognitive-support ingredient—as a valuable component in various health and wellness formulations. As a result, citicoline witnessed broader adoption in dietary supplements, functional beverages, and medical nutrition products aimed at supporting mental clarity, focus, and cognitive resilience.
However, the pandemic also introduced significant operational constraints across the citicoline supply chain. Global lockdowns, travel restrictions, and production slowdowns created disruptions in raw material sourcing and logistics, leading to inconsistent supply and rising costs for manufacturers. Moreover, the tightening of regulatory frameworks in response to increasing consumer reliance on health supplements brought added pressure. Regulatory agencies, including the FDA and EMA, began enforcing stricter controls on labeling accuracy, safety profiles, and efficacy claims—necessitating greater investment in clinical validation and compliance, and ultimately extending product development timelines and raising operational burdens for market players.
At the same time, the crisis acted as a catalyst for rapid digital transformation within the industry. The accelerated adoption of e-commerce, direct-to-consumer (DTC) platforms, and telehealth services created new avenues for market expansion and consumer outreach. This shift not only enhanced the visibility of citicoline-based products globally but also empowered consumers to make more informed, health-conscious purchasing decisions. Additionally, the growing body of scientific research into the neurological complications linked to COVID-19 inspired renewed interest in citicoline’s therapeutic potential. Clinical studies exploring its role in cognitive recovery and neuroinflammation brought further validation to its benefits, strengthening its credibility in both the medical and nutraceutical communities.
In conclusion, while the COVID-19 pandemic posed significant supply, regulatory, and logistical challenges to the global citicoline ingredient market, it also unlocked new growth avenues. By elevating the importance of cognitive health, driving innovation in product delivery and distribution, and encouraging deeper clinical exploration, the pandemic ultimately positioned citicoline as a high-value ingredient in the evolving landscape of preventive and functional health. This shift has laid a solid foundation for sustained growth and product diversification in the post-pandemic era.
Pricing Analysis, 2024 (usd)
Pricing Analysis
Sr. No
Company Name
Type (Sodium Salt/Free base)
Average price/ kg (USD)
Kyowa Hakko Bio Co.
Market estimates by geography (2035)
InsightNA leads with $0.95M by 2035, while Asia-Pacific is projected to grow fastest at a 1.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2024 | 2035 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.34M | $0.33M | $0.32M | -0.4% | 16% |
| Europe | $0.36M | $0.36M | $0.35M | -0.1% | 18% |
| Asia-Pacific | $0.22M | $0.24M | $0.26M | 1.2% | 13% |
| South America | $0.04M | $0.04M | $0.03M | -1.8% | 2% |
| Middle East and Africa | $0.04M | $0.04M | $0.03M | -1.3% | 2% |
| NA | $0.95M | $0.95M | $0.95M | N/A | 49% |
| Total | $1.95M | $1.95M | $1.95M | 6.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$475.78M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Citicoline Free Base | $727.98B | 7.3% | 64% |
| Citicoline Sodium Salt | $400.43B | 5.2% | 35% |
| Microbial Fermentation | $293.22M | 7.2% | 0% |
| Personal Wellness | $269.35M | 6.1% | 0% |
| Chemical Synthesis | $182.56M | 5.7% | 0% |
| Sports Nutrition | $138.48M | 8.6% | 0% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Citicoline Ingredients Market covering market dynamics, competitive landscape, and strategic outlook.
The Citicoline Ingredients Market market is projected to reach $475.78M by 2035, growing at 6.6% CAGR. The Citicoline Free Base segment holds the largest share.
Introduction
The increasing incidence of various diseases worldwide, the growing number of product launches featuring citicoline, and the rising adoption of preventive and personalized nutrition are key factors driving the growth of the global citicoline ingredient market. However, stringent regulatory policies and a lack of consumer awareness in emerging markets are expected to hamper market expansion. Nevertheless, the growing geriatric population and the heightened focus on mental health and wellness in the post-pandemic era are anticipated to create lucrative opportunities for industry.
Increasing incidences of various diseases across the globe
The rising prevalence of neurological and age-related disorders—such as stroke, Alzheimer’s disease, dementia, and glaucoma—is significantly driving the growth of the global citicoline ingredient market. As these conditions continue to affect an increasing segment of the population, particularly the elderly, there is growing demand for therapeutic and preventive solutions that support brain health and cognitive function.
For instance, according to the World Health Organization, approximately 55 million people worldwide were living with dementia in 2023, with over 60% residing in low- and middle-income countries. In July 2023, the Stroke Awareness Foundation reported that ischemic stroke is the most common type, accounting for about 87% of all strokes. Nearly 795,000 people suffer from strokes each year in the United States, with one occurring every 40 seconds and approximately four stroke-related deaths every hour.
In 2024, nearly seven million Americans were over the age of 75, representing 73% of the elderly population. Additionally, in March 2023, the Canadian Association of Optometrists identified glaucoma as one of the leading causes of vision loss, affecting nearly 450,000 Canadians. The Government of Canada also reported that nearly 477,000 individuals were diagnosed with dementia between April 2020 and March 2021.
Moreover, Biogen International GmbH noted that approximately 14.1 million people were living with dementia in 2019, making it the second-highest prevalence globally. According to the CSIR–National Institute of Science Communication and Policy Research, India ranked as the fourth-largest contributor to the global burden of dementia, with 3.69 million cases reported in 2019.
The growing awareness of citicoline’s potential benefits in enhancing memory, focus, and overall neurological health is encouraging its incorporation into a broad range of health products, thereby propelling market growth.
Growing product launch associated with CITICOline
The growing number of product launches featuring citicoline as a key ingredient is significantly driving the expansion of the citicoline ingredient market. Companies across the nutraceutical, pharmaceutical, and functional food sectors are increasingly incorporating citicoline into their products due to its recognized benefits for cognitive health, mental clarity, and neuroprotection. For instance, in February 2024, Karma Water (US) launched Cognizin, a caffeine-based energy drink, at Natural Products Expo West. This health-conscious, functional beverage is designed to provide energy and mental clarity throughout the day. Similarly, in June 2023, Launch Hydrate (US) entered the sports drinks market with products containing essential vitamins, minerals, and electrolytes. Instead of caffeine, these beverages feature Cognizin—a branded citicoline ingredient marketed by Kyowa Hakko Bio Co., Ltd. (Japan)—to support focus and attention. These innovative formulations, ranging from memory-enhancing supplements to brain health beverages, are not only broadening the consumer base but also enhancing the market visibility of citicoline. As more brands highlight citicoline’s scientifically supported role in cognitive enhancement, consumer awareness and demand continue to rise, fueling a positive cycle of innovation and market growth.
Growing Adoption of Preventive and Personalized Nutrition
The accelerating shift toward preventive and personalized nutrition is emerging as a key growth driver for the global citicoline ingredient market. Citicoline, a naturally occurring brain compound recognized for its cognitive-enhancing benefits, is increasingly being integrated into dietary supplements and functional food formulations. As health-conscious consumers particularly aging populations and performance-focused individuals seek proactive solutions to support cognitive function, memory, and mental clarity, demand for citicoline-based products is rising steadily. Concurrently, the rise of personalized nutrition, which aligns supplementation with individual health profiles and genomic data, is further fueling this growth trajectory. In response, manufacturers are leveraging this market momentum by launching differentiated, citicoline-infused offerings that align with evolving consumer expectations. This confluence of preventive healthcare and customization is positioning citicoline as a critical ingredient in the future of health and wellness, driving sustained market expansion and deeper penetration across global nutraceutical sectors.
The growing geriatric population across the globe is significantly driving demand for cognitive health solutions, creating lucrative growth opportunities in the global citicoline ingredient market. As aging individuals are more susceptible to cognitive decline, neurodegenerative conditions such as Alzheimer's and dementia, and general age-related memory impairment, there is an increasing need for safe and effective cognitive support ingredients like citicoline. In Europe one of the most aged regions globally— the demand for brain health supplements and functional foods enriched with citicoline is on the rise, as elderly populations seek to maintain mental clarity and delay the onset of cognitive disorders. According to the European Commission, more than one-fifth of Europe's 448.8 million residents are aged 65 or older, highlighting a strong consumer base for cognition-enhancing ingredients. Similarly, countries across Asia-Pacific, including Japan, China, and South Korea, are experiencing rapid demographic shifts toward aging populations. This is fueling investment in senior health products and long-term care solutions, with citicoline gaining attention as a scientifically backed ingredient for focus, memory, and neuroprotection.
For example, as noted in the Asia-Pacific Report on Population Ageing 2022, the region had approximately 670 million people aged 60 or older in 2022, a figure projected to nearly double by 2050. In the GCC region, rising life expectancy coupled with national health strategies and investments in personalized nutrition and preventive healthcare are fostering the adoption of citicoline-based supplements and functional beverages. In South America, particularly in Brazil and Argentina, a growing elderly population along with improved healthcare access is expanding the market for brain health products that incorporate citicoline. Meanwhile, in Africa, though the population remains relatively young, increasing longevity and improved healthcare access are gradually creating demand for affordable cognitive support supplements. Across all these regions, the rise in aging populations—paired with increased awareness of brain health, preventive care, and the benefits of ingredients like citicoline—is prompting healthcare providers, supplement manufacturers, and governments to support wider availability of cognitive enhancement products.
This trend is unlocking significant growth potential for both global and regional players in the citicoline ingredient market. -PAND EMIC The post-pandemic landscape has ushered in a profound and sustained increase in global focus on mental health and wellness, which is driving lucrative growth opportunities for the global citicoline ingredient market. The COVID-19 pandemic not only highlighted the critical importance of mental resilience but also exacerbated issues such as stress, anxiety, cognitive fatigue, and declining memory among diverse populations. As a result, consumers have become more proactive in seeking scientifically validated solutions to support brain health and cognitive function. Citicoline, a naturally occurring compound known for its neuroprotective and cognitive-enhancing effects, has garnered significant attention within the nutraceutical and functional food sectors as a premium in redient to address these emer in needs Increasin research substantiatin citicoline’s role in improvin memory, focus, and mental clarity has further accelerated its adoption. Additionally, the rising prevalence of remote work, digital fatigue, and aging populations has amplified the demand for supplements that help maintain mental acuity and emotional balance.
Manufacturers are capitalizing on this heightened consumer awareness by innovating and launching targeted citicoline-enriched formulations designed to meet the evolving demands of mental health-conscious consumers. This combination of heightened consumer demand, ongoing scientific validation, and product innovation is propelling the citicoline ingredient market toward strong, sustainable growth and expanding its footprint across global wellness and healthcare markets.
Stringent regulatory policies
Stringent regulatory policies present a significant restraint on the growth trajectory of the global citicoline ingredient market. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce rigorous approval processes that require extensive preclinical and clinical trials. These lengthy procedures demand substantial financial investment and time, posing challenges for manufacturers aiming to bring citicoline-based products to market. In addition, compliance with strict labeling and marketing regulations necessitates robust scientific evidence to support health claims related to cognitive benefits, further complicating product development and commercialization. Adherence to international quality control standards and country-specific regulations also introduces operational complexities and increases costs for industry players. For example, in 2019, the American Academy of Neurology reported that the FDA issued 12 warning letters and five advisory letters targeting companies making unverified claims about dietary supplements for dementia and Alzheimer’s disease—many of which were marketed online or via social media. That same year, the FDA also sent a warning letter to Pure Nootropics, LLC (US), stating that its citicoline-based products marketed for enhanced cognition were considered unsafe and ineffective.
Under Section 201(p) of the Federal Food, Drug, and Cosmetic Act, these products qualified as "new drugs," requiring FDA approval under Sections 301(d) and 505(a) before entering interstate commerce. Such regulatory barriers not only hinder new entrants but also restrict the broader adoption of citicoline-based products, ultimately limiting their potential to meet unmet medical needs and improve global patient outcomes.
Lack of Consumer Awareness in Emerging Markets
The lack of consumer awareness in emerging markets remains a significant barrier restraining the growth of the global citicoline ingredient market. Despite the proven cognitive and neuroprotective benefits of citicoline, its recognition among consumers in regions such as Southeast Asia, Africa, and parts of Latin America remains limited. In these markets, citicoline is often overshadowed by more established brain health ingredients like omega-3 fatty acids or ginkgo biloba, due in part to minimal marketing efforts, insufficient healthcare practitioner advocacy, and limited access to scientifically grounded information. Additionally, lower healthcare literacy and a focus on immediate or visible health issues, rather than long-term cognitive well-being, reduce the priority given to brain health supplements. This gap in consumer education hinders demand, discourages product innovation, and limits the willingness of local brands and retailers to invest in citicoline-based offerings. Without targeted awareness campaigns, strategic collaborations, and healthcare professional engagement, the market potential for citicoline in these regions will remain underdeveloped, restraining overall global market expansion.
The growing geriatric population across the globe is significantly driving demand for cognitive health solutions, creating lucrative growth opportunities in the global citicoline ingredient market. As aging individuals are more susceptible to cognitive decline, neurodegenerative conditions such as Alzheimer's and dementia, and general age-related memory impairment, there is an increasing need for safe and effective cognitive support ingredients like citicoline. In Europe one of the most aged regions globally—the demand for brain health supplements and functional foods enriched with citicoline is on the rise, as elderly populations seek to maintain mental clarity and delay the onset of cognitive disorders. According to the European Commission, more than one-fifth of Europe's 448.8 million residents are aged 65 or older, highlighting a strong consumer base for cognition-enhancing ingredients. Similarly, countries across Asia-Pacific, including Japan, China, and South Korea, are experiencing rapid demographic shifts toward aging populations. This is fueling investment in senior health products and long-term care solutions, with citicoline gaining attention as a scientifically backed ingredient for focus, memory, and neuroprotection.
For example, as noted in the Asia-Pacific Report on Population Ageing 2022, the region had approximately 670 million people aged 60 or older in 2022, a figure projected to nearly double by 2050. In the GCC region, rising life expectancy coupled with national health strategies and investments in personalized nutrition and preventive healthcare are fostering the adoption of citicoline-based supplements and functional beverages. In South America, particularly in Brazil and Argentina, a growing elderly population along with improved healthcare access is expanding the market for brain health products that incorporate citicoline. Meanwhile, in Africa, though the population remains relatively young, increasing longevity and improved healthcare access are gradually creating demand for affordable cognitive support supplements. Across all these regions, the rise in aging populations—paired with increased awareness of brain health, preventive care, and the benefits of ingredients like citicoline—is prompting healthcare providers, supplement manufacturers, and governments to support wider availability of cognitive enhancement products. This trend is unlocking significant growth potential for both global and regional players in the citicoline ingredient market.
Increased Focus on Mental Health and Wellness Post-Pandemic
The post-pandemic landscape has ushered in a profound and sustained increase in global focus on mental health and wellness, which is driving lucrative growth opportunities for the global citicoline ingredient market. The COVID-19 pandemic not only highlighted the critical importance of mental resilience but also exacerbated issues such as stress, anxiety, cognitive fatigue, and declining memory among diverse populations. As a result, consumers have become more proactive in seeking scientifically validated solutions to support brain health and cognitive function. Citicoline, a naturally occurring compound known for its neuroprotective and cognitive-enhancing effects, has garnered significant attention within the nutraceutical and functional food sectors as a premium ingredient to address these emerging needs. Increasing research substantiating citicoline’s role in improving memory, focus, and mental clarity has further accelerated its adoption. Additionally, the rising prevalence of remote work, digital fatigue, and aging populations has amplified the demand for supplements that help maintain mental acuity and emotional balance.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Citicoline Ingredients Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Company Headquarters: Florida, US Founded: 2005 Workforce: ~100 Company Working: LGM Pharma is one of the active pharmaceutical ingredient companies that offers API sourcing as well as drug product contract development and manufacturing solutions to the biotechnology, pharmaceutical, and compounding pharmacy industries. It has ISO 9001:2015 certification. The company has an unparalleled network of prequalified cGMP API manufacturers around the globe. It has US-based manufacturing and warehouse facilities and has delivered more than 6,000 APIs to its clients in the last three years.
8 interactive charts drawn from the Citicoline Ingredients Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Citicoline Ingredients Market By Region
Global Citicoline Ingredients Market By Manufacturing Process
Global Citicoline Ingredients Market By Alzheimer’S Disease
Global Citicoline Ingredients Market By Country
Global Citicoline Ingredients Market By Application
Global Citicoline Ingredients Market By Formulation
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
